SOLENO THERAPEUTICS INC (SLNO) Stock Analyst Earnings Estimates
NASDAQ:SLNO - Nasdaq - US8342033094 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 610K | 1.649M -100.00% | 271.32K | 38.078M | 173.26M 355.01% | |||||||||
| EBITDA YoY % growth | -5.13M | -12.05M -134.89% | N/A 32.03% | N/A -28.94% | N/A -16.86% | N/A -74.47% | N/A -59.50% | N/A 13.89% | N/A 24.11% | N/A -75.70% | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.16M | -12.16M -135.66% | -14.59M 31.58% | -10.821M -46.27% | -18.473M -17.50% | -23.829M -64.27% | -37.078M -54.49% | -36.973M 13.12% | -26.45M 22.61% | -37.192M -69.61% | -180.712M -336.67% | -124.132M 31.31% | -50.733M 59.13% | |
| Operating Margin | N/A | -1,993.44% | -884.78% | -3,988.35% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -325.99% | -29.28% | |
| EPS YoY % growth | N/A | N/A | -82.62 56.28% | -18.21 67.27% | -14.99 38.30% | -10.20 13.97% | -6.83 48.84% | -6.66 11.36% | -3.50 43.25% | -2.52 10.54% | -4.31 -45.04% | -2.82 34.49% | -1.20 57.35% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.18 -256.48% | -0.77 -30.09% | -0.63 -10.95% | -0.57 68.79% | -0.44 62.50% | -0.67 12.29% | -0.66 -4.84% | -0.63 -10.71% | -0.47 -6.36% |
| Revenue Q2Q % growth | 339.997K | 3.927M | 8.288M | 16.687M | 5.437M 1,499.13% | 6.528M 66.23% | 7.834M -5.48% | 15.902M -4.70% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -50.182M -260.76% | -33.612M -43.18% | -25.443M -2.31% | -22.013M 72.56% | -14.466M 71.17% | -29.04M 13.60% | -28.531M -12.14% | -27.673M -25.71% | -20.524M -41.88% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.83 -92.63% | -0.64 | -1.19 | -186.49% |
| Q2 2024 Q2Q % growth | -0.57 29.63% | -0.61 | 0.04 | 6.60% |
| Q1 2024 Q2Q % growth | -0.59 32.95% | -0.38 | -0.21 | -57.04% |
| Q4 2023 Q2Q % growth | -0.33 43.10% | -0.28 | -0.05 | -18.37% |
| Q3 2023 Q2Q % growth | -0.95 -25.00% | -0.59 | -0.36 | -61.51% |
| Q2 2023 Q2Q % growth | -0.81 10.00% | -0.84 | 0.03 | 3.94% |
| Q1 2023 Q2Q % growth | -0.88 18.52% | -0.74 | -0.14 | -19.00% |
| Q4 2022 Q2Q % growth | -0.58 3.33% | -0.82 | 0.24 | 28.92% |
| Q3 2022 Q2Q % growth | -0.76 49.33% | -0.93 | 0.17 | 18.12% |
| Q2 2022 Q2Q % growth | -0.90 57.14% | -0.92 | 0.02 | 1.96% |
| Q1 2022 Q2Q % growth | -1.08 34.55% | -1.07 | -0.01 | -0.84% |
| Q4 2021 Q2Q % growth | -0.60 | -1.30 | 0.70 | 53.86% |
| Q3 2021 Q2Q % growth | -1.50 9.09% | -1.68 | 0.18 | 10.87% |
| Q2 2021 Q2Q % growth | -2.10 12.50% | -1.63 | -0.47 | -28.67% |
| Q1 2021 Q2Q % growth | -1.65 15.38% | -1.17 | -0.48 | -40.66% |
| Q4 2020 Q2Q % growth | -0.60 88.89% | -1.07 | 0.47 | 43.98% |
| Q3 2020 Q2Q % growth | -1.65 -466.67% | -1.33 | -0.32 | -24.43% |
| Q2 2020 Q2Q % growth | -2.40 48.39% | -3.14 | 0.74 | 23.48% |
| Q1 2020 Q2Q % growth | -1.95 40.91% | -3.01 | 1.06 | 35.20% |
| Q4 2019 Q2Q % growth | -5.40 | -2.45 | -2.95 | -120.59% |
| Q3 2019 Q2Q % growth | 0.45 | -2.45 | 2.90 | 118.38% |
| Q2 2019 Q2Q % growth | -4.65 | -2.68 | -1.97 | -73.67% |
| Q1 2019 Q2Q % growth | -3.30 | -4.44 | 1.14 | 25.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -17.69% | -17.69% | -2.05% | -50.77% |
| Revenue | N/A | N/A | N/A | N/A |